The KEGG pathways indicated that FBXO32 was related to ECM–receptor interaction, PI3K-Akt signaling pathway, proteoglycans in cancer, and regulation of actin cytoskeleton (Figure 8F). This evidence concerns the gene FBXO32 and cancer.